Home › Funds › CastleKnight Management LP › PAHC

CastleKnight Management LP position in PAHC

PHIBRO ANIMAL HEALTH CORP · Health Care

CastleKnight Management LP reported holding 461,322 shares of PAHC (PHIBRO ANIMAL HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$14.5M, representing 0.41% of its reported portfolio and ranking #37 among its reported holdings. CastleKnight Management LP has disclosed PAHC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)461.32K sh
Reported value held$14.49M
Portfolio Weight0.41%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CastleKnight Management LP's PAHC position evolved

CastleKnight Management LP first disclosed a stake in PAHC in Q3 2023 at 47,837 shares (US$611K). The position peaked in Q3 2025 at 399,783 shares, worth US$16.2M. Across 12 filings, CastleKnight Management LP increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 461,322 shares valued at US$14.5M — an increase of 385,427 shares quarter over quarter.. Notable position changes include a 101% increase in Q1 2024 (shares rose 30% over the following quarter), a 158% increase in Q2 2024 (shares rose 34% over the following quarter), a 508% increase in Q2 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 47.84K $610.88K New
Q4 2023 47.84K $553.95K Hold
Q1 2024 96.34K $1.25M Add
Q2 2024 248.64K $4.17M Add
Q3 2024 366.64K $8.26M Add
Q4 2024 389.43K $8.18M Add
Q1 2025 417.75K $8.92M Add
Q2 2025 531.35K $13.57M Add
Q3 2025 399.78K $16.18M Reduce
Q4 2025 240.90K $9.00M Reduce
Q1 2026 75.89K $4.20M Reduce
Q2 2026 461.32K $14.49M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PAHC and 13F data

PAHC (PHIBRO ANIMAL HEALTH CORP) is a Health Care company. 28 other funds we track also report a position in PAHC — the largest reported positions include GLOBEFLEX CAPITAL L P (US$5.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PAHC

All PAHC fund holders →

FAQ

How long has CastleKnight Management LP held PAHC?

CastleKnight Management LP has disclosed PAHC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is CastleKnight Management LP's current position in PAHC?

As of Q2 2026, CastleKnight Management LP holds 461.32K shares of PAHC (PHIBRO ANIMAL HEALTH CORP), valued at $14.49M, representing 0.41% of its reported portfolio and ranking #37.

Has CastleKnight Management LP been buying or selling PAHC?

In the latest 13F filing (Q2 2026), CastleKnight Management LP increased its position in PAHC. The position peaked in Q3 2025 at 399.78K shares.

Which other funds hold PAHC?

Other major institutional holders of PAHC include GLOBEFLEX CAPITAL L P, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.